Bioorganic and Medicinal Chemistry p. 5311 - 5326 (2017)
Update date:2022-08-15
Topics:
Yamagishi, Hiroaki
Inoue, Takayuki
Nakajima, Yutaka
Maeda, Jun
Tominaga, Hiroaki
Usuda, Hiroyuki
Hondo, Takeshi
Moritomo, Ayako
Nakamori, Fumihiro
Ito, Misato
Nakamura, Koji
Morio, Hiroki
Higashi, Yasuyuki
Inami, Masamichi
Shirakami, Shohei
Janus kinases (JAKs) play a crucial role in cytokine mediated signal transduction. JAK inhibitors have emerged as effective immunomodulative agents for the prevention of transplant rejection. We previously reported that the tricyclic imidazo-pyrrolopyridinone 2 is a potent JAK inhibitor; however, it had poor oral absorption due to low membrane permeability. Here, we report the structural modification of compound 2 into the tricyclic dipyrrolopyridine 18a focusing on reduction of polar surface area (PSA), which exhibits potent in vitro activity, improved membrane permeability and good oral bioavailability. Compound 18a showed efficacy in rat heterotopic cardiac transplants model.
View MoreJiaozuo Zhongwen Trading Coporation Limited
Contact:+86 0391-3553810
Address:East Renmin Road
Chengdu CSH Pharmaceutical Co.,ltd
Contact:+86-(28)-85321971
Address:Block B,New Hope Int. Tian Fu New District, Chengdu, Sichuan, China
Cerametek Materials(ShenZhen)Co., Ltd.
Contact:+86-755-2324.2554
Address:A3-#9, YongChuan Street, Suite 501
Shanghai Yuking Water Soluble Material Tech Co., Ltd
Contact:86-21-68286299
Address:4F, 13B, No. 600, South Xinyuan Road 201306, Shanghai, China
Jining Shengrun Chemical Industry Co., Ltd.
Contact:+86-537-7121666 ,
Address:West Ring Road,Wenshang County Shandong Province
Doi:10.1002/ardp.19642970404
(1964)Doi:10.1007/BF00956540
()Doi:10.1039/c8cc00445e
(2018)Doi:10.1021/ja01202a060
(1947)Doi:10.1021/acs.orglett.6b01696
(2016)Doi:10.1016/j.bmc.2007.01.052
(2007)